Resolving the genetic basis of complex diseases like rheumatoid arthritis will require knowledge of the corresponding diseases in experimental animals to enable translational functional studies. Mapping of quantitative trait loci in mouse models of arthritis, such as collagen-induced arthritis (CIA), using F 2 crosses has been successful, but can resolve loci only to large chromosomal regions. Using an inbred -outbred cross design, we identified and fine-mapped CIA loci on a genome-wide scale. Heterogeneous stock mice were first intercrossed with an inbred strain, B10.Q, to introduce an arthritis permitting MHCII haplotype. Homozygous H2 q mice were then selected to set up an F 3 generation with fixed major histocompatibility complex that was used for arthritis experiments. We identified 26 loci, 18 of which are novel, controlling arthritis traits such as incidence of disease, severity and time of onset and fine-mapped a number of previously mapped loci.
INTRODUCTION
Rheumatoid arthritis (RA [MIM 830300]) is an autoimmune disease involving a chronic inflammatory and destructive attack on peripheral joints. In spite of massive efforts, little is known about what mechanisms trigger and perpetuate disease. Susceptibility to RA is largely dependent on genetic factors, which has raised hope that the pathogenesis could eventually be understood by identifying the underlying genes (1) . Genome-wide studies have identified 30 loci associated with RA, but each has only a small impact on disease and the understanding of the functional importance of the polymorphisms will be a major challenge (2, 3) . Animal models are invaluable tools for achieving this. Gene identification in animal models, which allows large linkage studies in strictly controlled environments, has previously proven successful in identifying new susceptibility genes controlling quantitative traits (4 -7) . The most commonly used mouse model of RA is collagen-induced arthritis (CIA) that shares many disease characteristics with RA (8, 9) . More than 40 loci (www.jax. org) controlling different aspects of CIA have already been identified in crosses between inbred strains, but so far only the Cia1 locus has had its underlying gene, encoding major histocompatibility complex (MHC) class II A beta, identified conclusively (10) (11) (12) . However, a locus on chromosome 2 (Cia2/4) also has a very strong candidate gene. It maps to the Hc gene, encoding complement factor 5 (C5). A variant of this gene has a 2 bp deletion that causes C5 deficiency. C5 is essential for the development of CIA, and it is therefore widely believed that this deletion is causative of the locus (13) (14) (15) . However, the Cia2/4 locus region stretches over most of the upper half of chromosome 2, and the region has not been fine-mapped to show that the Hc gene is singly responsible for the effect on arthritis (16, 17) .
The most common way to identify quantitative trait locus (QTL) in mice is through two-generation crosses. These have low resolution and are usually limited to identifying large locus regions making the process from mapping the locus to identifying the causal gene(s) cumbersome and time consuming. It has recently been shown that mapping of QTL in heterogeneous stock (HS) mice can be an efficient way to both narrow down known locus regions and identify new loci (18 -21) . HSs are advanced intercross lines in which several founder strains are intercrossed for a large number of generations, resulting in a fine mosaic of founder strain haplotypes. The short distance between recombinations and the known ancestry of HS mice makes it possible to map QTL with high resolution within a relatively short time period. HSs could thus provide a much needed possibility to proceed from the large locus regions identified in twogeneration crosses to small regions that would allow efficient identification of the disease-affecting genes.
So far, only one study has been published where QTL mapping was done in HS mice on a genome-wide level (19) . This study demonstrated that the method is useful for mapping of complex traits but also that the complicated structure of the cross demands special analysis methods.
One limitation of HS mice is that the phenotypes that can be investigated are restricted by the strains originally introduced in the cross. The Northport HS includes both strains that are likely to have alleles that make them highly susceptible to CIA and strains that are likely to be less susceptible making mapping of arthritis genes in this stock an attractive prospect (21) (22) (23) (24) . However, CIA can only be induced efficiently in strains that have an MHC class II haplotype that present the immunodominant peptides of type II collagen (CII) well, which none of the founder strains of the stock have (10) . In fact, immunization of the HS mice with CII revealed an almost complete resistance to CIA (25) .
Therefore, we considered using a variant of the suggested inbred -outbred cross (26) strategy to introduce arthritis permitting MHC alleles into the HS by crossing them with an inbred strain, C57BL/10.Q (BQ), that has an arthritis allowing H2 q haplotype (Supplementary Material, Fig. S1 ). The BQ strain develops arthritis with an intermediate incidence and severity after immunization with rat collagen in Complete Freund's adjuvant (CFA), making it ideal to map both protective and disease promoting genes. Consequently, it has frequently been used in genetic and functional studies of CIA.
In this article, we describe the results of an arthritis experiment that was performed on 1764 HSxBQ mice. We mapped 26 loci controlling arthritis and arthritis-related traits namely sum score, incidence, severity and onset of disease. Our study illustrates usefulness of both ordinary HS mice and inbred -outbred mice in QTL mapping but also the complexity of arthritis genetics and the limitations of advanced intercrosses when studying highly complex phenotypes.
RESULTS

Arthritis
The HSxBQ mice were more susceptible, but developed arthritis with a similar disease course and macroscopic appearance as pure BQ mice. Like BQ mice, male mice had higher incidence and severity of arthritis than female mice (Supplementary Material, Fig. S2 ). The HSxBQ mice developed arthritis with an incidence of 40% in females and 67% in males after a single immunization with rat CII emulsified in low-dose CFA. Male mice also had earlier onset of disease; mean day of onset was day 30 in males and day 35 in females.
QTL mapping
Single locus linear model. Instead of applying a regression model to each single nucleotide polymorphism (SNP) independently, we inferred the founder haplotype structure for each mouse using the HAPPY algorithm and applied the regression to the inferred haplotypes within each interval between adjacent SNPs (27) . This method was used for analysis of the only genome-wide study of HS mice published so far and has been shown to have considerably better power to detect loci than single-point methods when the strain allele distribution of the causative polymorphism is different from the allele distribution of the flanking markers (19, 27) . This method indicated numerous loci surpassing the level of permutation-based genomewide significance (2logP . 4.8) (Fig. 1) , the strongest of which corresponded to the known Cia2/4 and Cia9 loci (Fig. 2) . Out of 43 known CIA loci [www.jax.org, (28)], 22 had genome-wide significant loci within 10 Mbp from the peak marker of the published locus (Table 1) . However, most published arthritis QTL have large, badly defined confidence intervals, making it impossible to prove that they are identical to the loci mapped in the HS mice.
It is often assumed that HSs and other advanced intercrosses can be analysed as if all individuals were unrelated or as if they were all equally related as in an F 2 cross. It is, however, obvious that these assumptions are violated and it has been demonstrated in simulations that false positive signals need to be handled (29) . However, no single method has been shown to solve this problem. We applied two additional mapping methods that take relatedness into account to identify the best supported loci and minimize the risk of false positive signals.
Single locus mixed model (random effect method). One method to handle confounding relationships is to include relatedness as a variable, using a mixed model/random effects method (30) . We used a random effects model to account for sibship effects. With this model, eight loci reached genome-wide significance for sum score of arthritis ( Table 2 ). The strongest association was with the Hc locus on chromosome 2 (P ¼ 10 211 ). Because this is a well-characterized locus, we considered it a positive control for the study. To exclude false positive spurious associations due to this strong locus and maximize the power to identify new loci, we repeated the analysis with the peak marker (rs13476427) included in the regression model. After this correction one locus, 4_149, no longer reached the threshold for significance (2logP . 4.6). In return, five new significant loci appeared (Table 2) .
Multi-locus model. The resample model inclusion probability (RMIP) method is another method to identify the most stable associations. This is a bootstrap-based method that uses forward selection to fit multi-locus models in subsets of the individuals. A model inclusion probability is calculated based on how often each marker is included in each multiple QTL model generated from the resampled data. Because the interval acting as the best proxy to a causal variant in the full data set may not be the best proxy for that variant in a resample, the RMIP attributed to a single causal variant can be spread over a group of neighbouring markers. We compensated for this by summing up peaks within a 5 Mbp window to get a range inclusion probability (range RMIP). A first round of analysis included the Hc region in 100% of the subsamplings (range RMIP ¼ 1) but with some spread within this region. We therefore decided to run the analysis with the rs13476427 marker included in the model as for the random effects model. This method identified 21 discrete loci, separated by at least 5 Mbp, with a range RMIP higher than 0.25 for at least one of the arthritis phenotypes: sum score, incidence, severity or onset of CIA, of which seven loci had a range RMIP ≥0.5 (Table 3) . Out of these 21 loci, 8 were located in previously mapped CIA QTL and 6 in regions known to control proteoglycan-induced arthritis (PGIA). Eight loci were in regions without previously mapped arthritis QTL (Table 3) .
Major CIA loci
Plots of results from the different analysis methods for the best supported loci are presented in Figure 2 . The correlation between analysis methods differs markedly between loci ranging from the locus on chromosome 1 at 173 Mbp, where all methods peak within a 50 kb region, to the more complex regions on chromosomes 2 and 8 where different methods give slightly differing results. Chromosome 1. We identified a QTL on chromosome 1 at 173.1 Mbp with a range RMIP of 0.95 ( Fig. 2A) . The QTL maps to the previously identified Cia9 locus (13) . The locus was associated with incidence (P ¼ 10
), severity (P ¼ 10 26.5 ) and sum score of CIA (P ¼ 10 215.8 ). The peak markers are situated within the Fc-receptor locus. Fc receptors play a central role in many immunological processes and disruption of their regulation contributes to development of several autoimmune diseases (31, 32) . Within this locus, Fcgr3 has previously been indicated to affect arthritis susceptibility in both mice and humans (33 -35) . Thus, our results support the Fc receptors as the main candidates for the Cia9 locus, and as some of the most important players in CIA. However, this is a gene-rich area, and the effect is likely to be contributed to by several genes, so further studies are required to exactly define the genetic polymorphisms.
One additional locus is mapped to chromosome 1 in this cross, mainly affecting incidence of disease (P inc ¼ 10
Mbp between the genes encoding complement factor H and the complement factor H-related protein 2, two highly plausible candidate genes considering the importance of complement activation in CIA. Moreover, factor H and related proteins are involved in several severe human immune diseases (36) .
Cia2/4 -C5 locus. The Hc gene, encoding the C5 protein, is the strongest candidate for any non-MHC locus for CIA, and C5-deficient mice are highly resistant to CIA (13, 37) . The Cia2 and Cia4 loci on chromosome 2 have both been claimed to be caused by a 2 bp deletion in the Hc gene that causes a frameshift and thereby early termination of transcription and subsequent C5 deficiency (13 -15) . However, the Cia2 locus was originally mapped to marker D2Mit61 which is situated at 60.5 Mbp, .25 Mbp from the Hc gene (17) . This discrepancy is explained by the results from the HSxBQ mice that indicate multiple loci on chromosome 2. As expected, the strongest of these (P sum ¼ 10 213.7 , range RMIP ¼ 1) corresponds to the C5 locus. In fact, the mixed model maps the locus exactly to the Hc gene. The peak marker, rs13476427, is a non-synonymous coding SNP within the Hc gene with a similar strain distribution as the 2 bp deletion. A simple single-marker association analysis also identifies SNPs within the Hc gene as the most significant (P ¼ 10
29.6
). By summing up the results of the different methods, the Hc gene would have been identified as the main candidate of the locus even without the prior knowledge; however, additional experiments would be needed to prove its causative and functional role since we could not exclude neighbouring genes such as Traf1.
Another peak on chromosome 2 at 63 Mbp, close to the original mapping of the Cia2 locus, is independent of the Hc locus (Fig. 3) . Interestingly, the peak marker (P sum ¼ 10 210.7 ) is situated just outside the Kcnh7 gene. The Ifih1-Gca-Kcnh7 locus has been linked to several autoimmune diseases in humans, including RA, multiple sclerosis and type 1 diabetes, making it a strong candidate gene for this locus (38) (39) (40) .
Chromosome 8. Interestingly, no less than four loci (P , 10
29.5
/range RMIP: 0.31 -0.5) are identified on chromosome 8 in a region that harbours no previously known QTL for CIA. There is, however, a locus controlling proteoglycan-induced arthritis (Pgia22) mapped to this region. Pgia22 was originally mapped in a cross between DBA/1 and BALB/C where no linkage to CIA was seen in the same cross, suggesting that the loci detected in our study could be independent of Pgia22 (41). Because the region contains multiple loci, the association seen at each marker in this region is affected by the nearby loci and the region should be highly susceptible to false positive associations and shifted peaks meaning that well-controlled breeding and production of congenic lines would be required to separate the effects of the loci and allow positional cloning of the underlying genes.
Chromosome 12. Chromosome 12 has not been implied in CIA before, but three loci are identified on it in this cross. The strongest locus, which almost exclusively affects incidence (P inc ¼ 10
210
, P severity ¼ 10 22.3 , P onset ¼ 10
21.6
, range RMIP ¼ 0.81), maps to 77.8 -77.9 Mbp.
Human loci
We were also interested to see whether we could find even more indications that the same genes affect human autoimmune diseases and CIA. We used a list of 32 confirmed loci affecting RA in humans (2) . The orthologues of three of these loci, HLA-DR4, TAGAP and CCR6, were found on chromosome 17 in the mouse within the fixed region and could not be analysed. One gene, CCL21, has no single equivalent in the mouse and was also excluded. Table 4 shows the maximum 2logP for any phenotype in the intervals containing the mouse orthologues. Six genes were in intervals that reached genome-wide significance for at least one phenotype.
DISCUSSION
In this study, we have shown the utility of the inbred -outbred cross to identify and fine-map loci affecting traits that are dependent on a specific genotype, such as MHC in this case. We mapped 26 loci robustly associated with CIA, adding 18 new loci for CIA. We were also able to fine map some of the previously known loci. Several of these loci appear to have small numbers of candidate genes in the peak region, making them excellent starting points for positional cloning efforts.
The mapping of a locus to Hc adds very strong evidence to support that this is the gene underlying this locus, which has been assumed but never proven. This can also be seen as a positive control demonstrating the precision of mapping. Results from chromosome 2 also illustrate one of the difficulties in genetic mapping of complex traits: it is clear that the Cia2 and Cia4 loci, reported in low resolution mapping experiments, are in fact caused by multiple loci (14, 17) . Even with the increased resolution of the HS cross, we could still not exclude the neighbouring TRAF1 gene region. However, since regulatory regions can operate at long distances, conclusions about the causative gene cannot necessarily be made, even if the causal variant is known, without additional experiments to address differences in expression and function of the surrounding genes.
The complex family structure of the HS mice and the very large number of arthritis regulating loci pose many difficulties for the analysis of the data. In this study, we used two different methods to account for the family structure (27, 29) . It is apparent that these give quite different results in some QTL regions. One explanation could be that these are loci that are made up of more than one locus which could be hypothesized to give quite different results with the two methods.
Genetic mapping in animal models is valuable to identify genes involved in the disease process as a strategy to find and investigate the pathogenic pathways. Reassuringly, but maybe surprisingly, several human RA loci had corresponding loci in this cross. We did not expect human loci to be represented since the selection of polymorphisms is more dependent of pathways than specific genes. In addition, the genetic pool of the cross is the equivalent of less than nine individuals, thus the identified genes are represented in these common inbred strains but will differ from a wild mouse population. Thus, while exactly the same disease-regulating genes are unlikely to be found in this particular mouse cross and humans, we believe that most of the causative gene polymorphisms will belong to pathways that are also important in human disease. Identifying these polymorphisms in mice will be important to provide animal models to study disease and develop new therapeutics. Notably, the effect size of a gene locus in a human disease or a disease model has no direct correlation with the involved pathways potential as a target for clinical therapy.
To provide conclusive evidence and to study the functional implications of a polymorphism underlying an identified QTL for a defined model for a human disease like RA which is normally not occurring in the wild mouse population, it is needed to produce congenic strains. Advantageously, in addition to providing detailed information about the position of a locus, the HS mice provide a resource for the production of congenic mice with selected recombinations that will not only provide evidence of the locus' existence but also facilitate finemapping and isolation of the QTL. There are also numerous peaks located within previously mapped loci for which congenic strains have already been generated. Even though some of these did not reach the limits for genome-wide significance set for this study, they will provide valuable information on the most likely candidates and best strategies to proceed with cloning efforts in these regions.
In association/linkage studies of simple populations, such as F 2 intercrosses or backcrosses, it is typical to report the uncertainty of the QTL location using confidence intervals defined by positional bootstrap (42) or by the decay of the association moving away from the peak (43) . In mapping of highly recombinant populations, the association does not drop with the distance from the peak in a statistically predictable manner but is subject to uncertainty due to local linkage disequilibrium. Studies like this where multiple loci contribute to the phenotype are even further complicated by the possible interference of signals from other loci, both neighbouring loci and ghost peaks from loci on other chromosomes that are caused by cryptic relatedness. We therefore decided not to present confidence intervals since none of the available methods could estimate them correctly.
Another method to proceed towards identification of the causal variant is to perform association-mapping under the peak to increase resolution. The success of this strategy would depend on the strain distribution of the variants as well as the number of recombinations in the region. Recently, the HS founder strains have been sequenced by the Sanger centre at a depth of 20 × coverage (http://www.sanger.ac.uk/resources/m ouse/genomes/). This resource will allow selection of SNPs to cover or tag haplotypes in regions of interest. Unfortunately, the BQ strain is not included in the sequencing project.
Analysing subphenotypes can also be valuable for finemapping of loci, as closely positioned loci that are difficult to distinguish can affect different subphenotypes and thereby be separated into smaller discrete intervals. Further, investigating human orthologues of the candidates in the mapped loci offers a way to maximize power to identify new genes by using mice for hypothesis-free generation of candidate genes.
In conclusion, we demonstrate the usefulness of a HS to determine the genetic control of a complex disease, using a model for RA. We were able to identify 26 arthritis loci, of which 18 are previously unknown, and fine map a number of previously known loci by using a previously untried strategy to utilize HS mice to map modifier QTL.
MATERIAL AND METHODS
Animals
The C57Bl/10.Q/Rhd mice (B10.Q or BQ) were received from Professor Jan Klein (Tübingen University, Germany). HS mice were a kind gift from Professor Robert Hitzemann (Oregon Health and Science University, USA). This stock, known as the Northport stock, is a cross between eight inbred strains: A/J, AKR/J, BALB/CJ, LP/J, CBA/2J, C3H/HeJ, C57BL/6J and DBA/2J. The stock had been kept as 48 breeding pairs using a circular breeding scheme for 55 generations until the start of our breeding. Our breeding setup is described in Supplementary Material, Figure S1 . The mice were bred and kept in a climate-controlled environment in the animal facility at the Department of Zoophysiology, Lund University. The mice were kept at a 12 h light/dark cycle, fed with regular rodent chow and water ad libitum. All experiments were approved by the local ethical authorities Malmö-Lund, Sweden (permit numbers: M70-04, M75-04).
MHCII screening
The F 2 generation was screened to identify mice with homozygous H2 q haplotype. Genomic DNA was used to perform standard polymerase chain reaction (PCR) for microsatellite genotyping. Microsatellite variants were dissolved using a MegaBACE DNA analysis system 1000 (Amersham Significant also with random effects correction for family structure.
Pharmacia Biotech, UK) according to the manufacturer's instructions. The following markers were used: D17mit146, D17mit230, D17mit47 and D17mit24. Parental strain PCR product lengths were determined using DNA from the founder strains (Jackson Laboratories, Bar Harbour, USA).
Experiment set-up
Offspring was collected from three litters. Experiments were performed in six batches; one batch of females and one batch of males from each litter. Experiments were started when the mice were 11-14 weeks old. Blood samples were collected in 10 U/ml heparin by retro-orbital bleeding 1 week before disease induction (day 27), two weeks after immunization (day 14) and at the termination of the experiment 7 weeks after immunization (day 50).
Arthritis induction and scoring
Arthritis was induced by an immunization at the base of the tail with 100 mg rat CII emulsified in 50 ml IFA and 25 mg Mycobacterium butyricum. The protocol was based on a pretitration experiment where it was decided to reduce the dose of M. butyricum from 50 to 25 mg when compared with the earlier described standard protocol (44) . The mice were scored to quantify inflammation at days 0, 19, 22, 25, 29, 36, 43 and 49 after immunization. The score of inflammation (defined by swelling and redness) was given by visual inspection of the paws as follows: 1 point/inflamed knuckle or toe +5 points for an inflamed ankle, giving a total of 15 points/paw. The scoring system has been described in detail previously (44) .
Genotyping
Genotyping was performed by the W.M. Keck Foundation Biotechnology Resource Laboratory at Yale University using a custom-designed Illumina mouse genotyping panel and genotypes were called using the BeadStudio Genotyping Module v3.2. One thousand seven hundred sixty-four HSxBQ mice were genotyped. In total, 8470 SNPs were genotyped, 7405 of which turned out to be polymorphic in the parental strains. Of these, 611 were fixed in the HSxBQ mice, but were included in the analysis since they still provide information about the strain of origin of the neighbouring markers. The average distance between informative markers was 0.38 Mbp.
Statistical analysis
Single locus mapping. The haplotype structure of the mice was inferred using the haplotype reconstruction method HAPPY (http://www.well.ox.ac.uk/happy/) (27) . In brief, HAPPY utilizes founder strain genotypes to calculate the probability F Li (s,t) that a locus interval L originates from founder strains s,t. Evidence of a QTL was calculated for each interval by fitting the regression model E(y i ) ¼ st F Li (s,t)T L (s,t) where T L (s,t) is the phenotype effect due to strains s,t at locus T. A 5% genome-wide significance threshold was determined by 200 permutations of the data set. For all analyses, the severity and onset phenotypes were normalized using box coxtransformation and age, sex and batch were used as covariates.
Resample model inclusion probability. The complex family structure of this type of population has been shown to increase the risk of false positive findings. A resampling-based multilocus modelling method has been developed to remedy this problem (29) . RMIP for loci was calculated by subsampling (n ¼ 60, subsample size 80%) with forward selection, adding loci to the model as long as the addition generated a P-value less than the 5% genome-wide significance threshold (adjusted to the subsample size) as previously described (29) . All loci were considered in the model selection. Closely spaced inclusion signals were assumed to originate from the same locus; therefore, inclusion signals within a 5 Mbp window were added to give a range probability (range RMIP), which for example changed the RMIP for the Hc/Traf1 locus on chromosome 2 from 0.11 to 1. The size of the window was arbitrarily chosen, however, using a 2 Mbp or a 10 Mbp window gave very similar results (data not shown).
Adjusting for family structure using mixed models with random effects. An alternative strategy to account for family structure is to use mixed models where family information is included as random effects variable in the regression expression (29, 30) . Family relationships among the animals were not recorded explicitly; however, breeding cage and date of birth implicitly contain information about sibship, and were used as random effects in the model. In addition, the experimental cage was introduced as a random effects variable to correct for environmental factors.
